Amlodipin HEXAL

Quick links to important sections

Amlodipin HEXAL

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Amlodipin HEXAL

Quick Facts

Property Description
Active ingredient Amlodipine
Form Oral tablet
Pharmacological class Calcium Channel Blocker (CCB)
Common use Circulatory management (e.g., high blood pressure)
Origin Synthetic compound

Identity, Classification, and Composition

Amlodipin HEXAL is a single-ingredient, prescription-only pharmaceutical product classified as a Calcium Channel Blocker (CCB). The active substance is Amlodipine (INN), a synthetic compound that is typically supplied as the besilate salt. Amlodipine is a medication used in circulatory care.

This medication is presented exclusively as an oral tablet, confirming its function as a monotherapy agent taken by mouth. It belongs specifically to the dihydropyridine derivative subclass of CCBs. This classification signifies its characteristic of exerting a preferential action on the smooth muscle cells of the blood vessels, rather than significantly impacting the heart's electrical rhythm.


The Role of Amlodipine in Circulatory Management

The fundamental general purpose of Amlodipine is to manage circulatory function as an effective antihypertensive agent. This class of medication works by promoting the relaxation and widening of the arteries, a process known as vasodilation.

By facilitating this dilation of peripheral and coronary arteries, Amlodipine helps to reduce the resistance against which the heart must pump blood. This decrease in systemic resistance contributes to the control of elevated blood pressure and is employed to relieve circulatory discomfort. Amlodipine provides a sustained benefit in maintaining consistent vascular resistance over a 24-hour period, supporting the patient's circulatory health.

Regulatory References

  1. WHO Model List of Essential Medicines
  2. Amlodipine - StatPearls - NCBI Bookshelf

What side effects are possible with Amlodipin HEXAL?

Possible side effects and safety information

This section describes the officially documented adverse reactions and safety characteristics of Amlodipine, strictly according to government regulatory classifications (e.g., FDA, EMA SmPC). The safety profile is organized by frequency and the body system affected.

Frequency and System-Organ Classification

The most frequent adverse reaction documented across clinical data is peripheral oedema (swelling), which is classified as Very Common (1/10). Other effects classified as Common (1/100 to < 1/10) include headache, dizziness, flushing (reddening of the skin), palpitations, nausea, and fatigue. These effects are often associated with the drug’s primary action on the Vascular and Nervous System Disorders organ classes, and certain effects, such as headache and flushing, may occur more frequently at the start of treatment.

Serious Adverse Reactions and Restrictions

Regulatory documents list certain rare events that are considered clinically significant. These Very Rare events (< 1/10,000) include severe conditions such as Angioedema, Pancreatitis, Hepatitis and Jaundice (hepatic toxicity), Myocardial Infarction, and severe cutaneous adverse reactions (SCAR) like Stevens-Johnson Syndrome.

Official prescribing information also establishes conditions that restrict the use of Amlodipine. The medicine is contra-indicated in patients experiencing severe hypotension, cardiogenic shock, or conditions involving obstruction of the outflow tract of the left ventricle (e.g., high-grade aortic stenosis).

Population-Specific Safety Notes

Safety notes specify that caution is warranted in older adults and individuals with hepatic impairment, as reduced drug clearance in these groups may lead to increased systemic exposure. For the treatment of hypertension, safety has been established for pediatric patients aged 6 to 17 years.

Overdose and Emergency Response

Overdose and When to Seek Help

This section describes the officially documented manifestations of amlodipine overdose and the regulator-mandated emergency actions.


Documented Overdose Manifestations

Domain Official Regulatory Statements
Documented Overdose Presentations Symptoms include profound and prolonged systemic hypotension, bradycardia, tachycardia, and somnolence.
Physiological Systems Affected Cardiovascular system (leading to shock and cardiovascular collapse) and central nervous system.
Dose-related Factors Gross overdosage can result in excessive peripheral vasodilation and subsequent serious cardiovascular events.
Population-specific Notes Patients with severe hepatic impairment require careful monitoring due to altered drug elimination.

Emergency Actions and Management

Classification Type Regulatory Statement
Severity Classification Can lead to life-threatening outcomes such as shock and non-cardiogenic pulmonary oedema.
Overdose-Context Constraints No specific antidote is known, and the substance is not dialyzable.
Immediate Help Required Seek immediate medical attention for any suspected overdose. Active cardiovascular support is required for clinically significant hypotension.

Official Overdose Statements:

  • Overdose may be manifested by profound, prolonged systemic hypotension and excessive peripheral vasodilation, potentially resulting in shock and cardiovascular collapse.
  • Immediate medical attention must be sought for any suspected overdose, and active cardiovascular support is required for clinically significant hypotension.
  • No specific antidote is known; management must focus on supportive measures and procedures such as gastric lavage or the administration of agents like Intravenous calcium gluconate.

Regulatory documents define the amlodipine overdose profile based on the dangerous exaggeration of its effect, which is excessive vasodilation, leading directly to profound hypotension and shock. The lack of a specific antidote means official emergency conditions are structured around immediate referral for continuous monitoring and the provision of symptomatic and supportive treatment to stabilize the patient's cardiovascular function.

Therapeutic Uses of Amlodipin HEXAL

What Amlodipin HEXAL Treats: Main Uses and Benefits

The core therapeutic applications of Amlodipin HEXAL focus on stabilizing circulatory function and managing cardiac discomfort. This medicine is primarily used for the long-term supportive management of hypertension (high blood pressure) and for the symptomatic treatment of various forms of angina.

This medication helps address symptoms related to systemic imbalance, specifically in conditions like chronic stable angina, vasospastic angina (Prinzmetal's angina), and documented Coronary Artery Disease (CAD). In high blood pressure, it plays a role in managing the risk of serious health issues related to cardiovascular functional stress. When used for angina, it generally assists in managing symptoms that create noticeable physiological strain by helping to ease the impact and reduce the frequency of distressing chest discomfort episodes.

“This medication generally contributes to maintaining functional stability and supports the easing of symptomatic discomfort related to reduced oxygen supply.”

In scenarios involving documented CAD, Amlodipin HEXAL is applied to provide a supportive role, which may assist in reducing the risk of hospitalization and may assist in reducing the necessity of future invasive procedures. This overall supportive role assists with general well-being during symptomatic phases.


Quick Fact: Support for Systemic Imbalance
Main Condition Treated Long-term supportive management of elevated blood pressure (Hypertension).
Symptom Relief Easing chest discomfort from stable and vasospastic angina.
Protective Role Supportive management in patients with documented Coronary Artery Disease.

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Amlodipin HEXAL

This section outlines the official population eligibility and non-eligibility rules for Amlodipine, as documented by government regulatory bodies.


Contraindicated and Restricted Populations

Category Regulatory Status
Absolute Contraindications Hypersensitivity to amlodipine, dihydropyridines, or any formulation component. Use is also contraindicated in states of severe hypotension, shock (including cardiogenic shock), or outflow tract obstruction (like high-grade aortic stenosis) [EMA/FDA equivalent].
Conditional Use Patients with severe hepatic impairment require caution; a lower starting dose is often specified due to reduced drug clearance. Small, fragile, or elderly patients may also be started on a lower dose [FDA equivalent].

Age and Physiological Status

Category Eligibility Rule
Adults Established as the primary eligible population for all labeled uses.
Children Use is established for the treatment of hypertension only in patients aged 6 to 17 years. Safety and effectiveness have not been established in children under 6 years of age [FDA equivalent].
Pregnancy Use is conditional; there are no adequate human studies, and use is generally only permitted if the documented benefit justifies the potential risk [NIH/FDA equivalent].
Lactation Amlodipine is excreted into human milk. The official recommendation is to discontinue breastfeeding or discontinue the drug, taking the drug’s importance into account [FDA equivalent].

These official regulatory statements define the boundaries for who is eligible to use Amlodipin HEXAL, establishing absolute prohibitions for certain acute cardiovascular conditions and defining restricted or unestablished use for specific age groups and physiological states.

What should I know about interactions with other medicines?

Amlodipin HEXAL (amlodipine) can interact with several other medicinal products and substance categories, primarily due to its metabolism by the CYP3A enzyme system in the liver. These interactions may result in changes in the blood concentration of amlodipine or the co-administered drug.

Documented Interacting Categories

Interacting Medicine/Category Effect on Drug Concentrations Clinical Relevance/Restriction
CYP3A Inhibitors (e.g., ketoconazole, diltiazem) Increase amlodipine exposure Requires monitoring for symptoms like excessive lowering of blood pressure and swelling; dose adjustment may be necessary.
CYP3A Inducers (e.g., rifampin) Decrease amlodipine exposure Requires close monitoring of blood pressure to ensure effectiveness is maintained.
Simvastatin (for high cholesterol) Increases simvastatin exposure The dose of Simvastatin must be limited to 20 mg daily when co-administered with amlodipine to reduce the risk of muscle problems.
Immunosuppressants (e.g., cyclosporine, tacrolimus) May increase exposure of immunosuppressant Frequent monitoring of the blood levels of the immunosuppressant is recommended, and the dose should be adjusted as appropriate.

Co-administration with other medicines that lower blood pressure, such as sildenafil, may also require monitoring due to the potential for excessive blood pressure reduction.

Mechanism of Action

How Amlodipin HEXAL Works

Amlodipine, the active substance in Amlodipin HEXAL, functions exclusively as a highly selective dihydropyridine calcium channel blocker, modulating vascular smooth muscle tone.


Targeted Blockade of Vascular Calcium Channels

The molecule's primary action is the direct blockade of L-type voltage-dependent calcium channels ( VDCCs), which are predominantly located in the smooth muscle cells of the arteries. This inhibition prevents the influx of calcium ions ( Ca^2+) necessary for the excitation-contraction coupling pathway. By limiting intracellular Ca^2+ availability, Amlodipine interrupts the molecular sequence that triggers muscle shortening, leading to the relaxation of the arterial walls.


Reducing Systemic and Coronary Vascular Resistance

This molecular action results in widespread peripheral vasodilation, meaning the resistance arteries widen. The physiological consequence of this widening is a reduction in Systemic Vascular Resistance (SVR), reducing the mechanical resistance encountered by the heart during ejection. Simultaneously, Amlodipine causes dilation of the coronary arteries, resulting in increased blood flow and oxygen delivery potential to the heart muscle tissue. Its unique kinetic profile, characterized by slow dissociation from the channel, contributes to a prolonged modulation of vascular tone.

Dosage and Administration Information

Instruction Map: How to use Amlodipin HEXAL — Administration Guidelines

Entity Description
Route of administration: Amlodipin is designed for administration via the oral route only, utilizing the tablet or oral solution dosage forms.
Dosing schedule: The usual adult starting dosage is 5 mg once daily, though an initial 2.5 mg dose is also used. The maximum recommended daily intake for all intended uses is 10 mg.
Timing in relation to meals (if applicable): The medication can be taken with or without food; however, it is structurally important to maintain administration at approximately the same time each day.
Age-group administration rules: A lower initial dose of 2.5 mg once daily is suggested for both older adults (geriatric patients) and those with documented hepatic insufficiency. For pediatric patients aged 6 to 17 years being treated for hypertension, the dose range is 2.5 mg to 5 mg once daily.
Missed-dose rules: If an administration time is missed, the dose should be taken as soon as the lapse is noted. If the time is near the next scheduled intake, the missed dose should be skipped entirely, and the next scheduled dose should be taken as planned; doses must not be doubled.

Connection to the overall use protocol

The use protocol for Amlodipine is structured as a once-daily oral regimen, independent of meal timing. This protocol involves a titration window of 7 to 14 days between dose adjustments to ensure the response to a specific dose level is fully assessed. Dose reductions are specified for patients based on age and hepatic function, defining the initial parameter for proper administration.

Recent Clinical Evidence

Recent Clinical Evidence

Amlodipin HEXAL contains the active substance amlodipine, a long-acting calcium channel blocker. Clinical studies predominantly evaluate its use for the treatment of hypertension (high blood pressure) and chronic stable angina (chest pain) or vasospastic angina.

Core Efficacy Findings

Studies have shown that amlodipine, when administered once daily, assists in the sustained control of blood pressure over a 24-hour period. In patients with high blood pressure, this action is linked to a reduction in peripheral vascular resistance, leading to lower blood pressure readings. Key findings supporting its use include:

  • Hypertension: Evidence from trials across different pharmacologic classes, including amlodipine, suggests that blood pressure reduction generally reduces the risk of cardiovascular events, such as stroke and heart attack.
  • Angina: Research indicates amlodipine helps alleviate the symptoms of chronic stable angina by increasing the supply of blood and oxygen to the heart muscle.

Combination Use and Specific Populations

Clinical trials often investigate amlodipine's use as a component of combination therapy. This approach recognizes that many individuals require multiple agents to achieve target blood pressure goals. Amlodipine is frequently studied in combination with other antihypertensive agents, such as ACE inhibitors or Angiotensin II Receptor Blockers (ARBs).

Separately, in patients with angiographically documented coronary artery disease and no severe heart failure, evidence suggests amlodipine may reduce the risk of hospitalization for angina and the need for coronary revascularization procedures.

Safety and Tolerability

Safety data collected across trials identify common side effects, which include peripheral edema (swelling of the ankles or feet), headache, and fatigue. The long elimination half-life of amlodipine contributes to a gradual onset of action, which may be associated with a lower incidence of some side effects compared to shorter-acting calcium channel blockers.

Key Studies & References

  1. Amlodipine - StatPearls (NCBI Bookshelf)

Frequently Asked Questions (FAQ)

Common questions about Amlodipin HEXAL (FAQ)


Q: How quickly does Amlodipin HEXAL start working after you begin taking it?

A: Amlodipin HEXAL is designed to work gradually. The official product information states that the highest concentration of the active substance in the blood is typically reached about 6 to 12 hours after taking an oral dose. This pattern supports the drug's sustained action over a 24-hour period.

Q: Will I feel a difference immediately after starting Amlodipin HEXAL?

A: Amlodipine is known for its gradual onset of action. Because it works slowly in the body, regulatory information notes that a sudden or excessive drop in blood pressure (acute hypotension) is rarely reported after taking the tablet. Consequently, patients generally do not feel an immediate change or sensation when beginning treatment.

Q: What happens if I stop taking Amlodipin HEXAL suddenly?

A: Regulatory information advises patients to always speak with a healthcare professional before making any change to their medication regimen, including stopping its use. For medications used to treat chest pain (angina), there is a general risk that abruptly stopping treatment could lead to a worsening of symptoms. Guidance on appropriate discontinuation is provided by a healthcare professional.

Q: Are there any major diet restrictions when taking Amlodipin HEXAL?

A: According to official product information, Amlodipin HEXAL can generally be taken with or without food. However, caution is advised regarding grapefruit or grapefruit juice. Consuming large amounts of grapefruit can increase the amount of amlodipine in the body, which may intensify the drug's effects and potential side effects.

Q: Can taking grapefruit or grapefruit juice affect Amlodipin HEXAL?

A: Yes, regulatory sources indicate that consuming grapefruit or grapefruit juice may affect Amlodipin HEXAL. Grapefruit can increase the blood levels of amlodipine. This could lead to a greater risk of side effects, such as a drop in blood pressure or increased swelling, and may require discussion with a healthcare professional.

Q: Does Amlodipin HEXAL interact with common pain relief medications like ibuprofen?

A: Official interaction data suggests that certain nonsteroidal anti-inflammatory drugs (NSAIDs), which include medications like ibuprofen, may reduce the blood pressure-lowering effects of amlodipine. Additionally, frequent combined use may carry a risk of affecting kidney function. Disclosure of all pain relievers to a prescriber is generally considered important for appropriate management.

Q: Is it possible to take Amlodipin HEXAL if I have diabetes?

A: Regulatory documents do not generally list diabetes as a contraindication for taking Amlodipin HEXAL on its own. However, when amlodipine is used as part of a combination product with other blood pressure medicines, specific restrictions may apply for patients with diabetes. Consultation with a healthcare professional is standard for reviewing pre-existing conditions.

Q: Are there any known issues with combining Amlodipin HEXAL and alcohol?

A: Official health guidance states that alcohol can contribute to the blood pressure-lowering effect of Amlodipin HEXAL. This combined effect may potentially lead to symptoms like dizziness, lightheadedness, or headaches. Official documents describe the need to address continued alcohol intake with a healthcare professional if these symptoms occur while using the medication.

Q: Can Amlodipin HEXAL change my heart rate?

A: The active substance amlodipine generally has a neutral effect on the heart rate. However, palpitations—a feeling of having a fast or irregular heartbeat—are listed among the documented side effects. Persistent changes in heart rhythm are typically reviewed by a healthcare professional.

Q: Do official documents mention weight gain as a side effect of Amlodipin HEXAL?

A: While fluid retention (oedema or swelling) is a very common side effect of amlodipine, weight gain itself is classified as a less common side effect. The less common occurrence is often related to the fluid retention associated with the drug. Rapid or significant weight change is generally reported to a doctor.

Q: Can Amlodipin HEXAL cause dry mouth?

A: Regulatory adverse event summaries generally do not list dry mouth (xerostomia) among the common or frequent side effects of Amlodipin HEXAL. While rare reports of this symptom may exist, it is not a typically expected or frequent reaction based on core regulatory documents.

Q: Are there any known interactions between Amlodipin HEXAL and herbal supplements?

A: Official regulatory documents stress the importance of telling a doctor about all medicines, herbs, and supplements being taken. This is necessary because many herbal products can influence the same enzyme systems (like CYP3A4) that process amlodipine, potentially altering its concentration in the blood.

Q: Is it true that Amlodipin HEXAL can affect gum health?

A: Yes, regulatory and medical literature recognizes that gingival hypertrophy (gum overgrowth) is a known, though uncommon, side effect associated with the class of drugs known as calcium channel blockers. Any changes noticed in the gums are typically discussed with a dentist or doctor.

Q: Is there a limit on how long a person can continuously take Amlodipin HEXAL?

A: Amlodipin HEXAL is approved for the long-term, chronic management of conditions like high blood pressure and angina. Official product information does not specify a maximum time limit for continuous use. Its long-acting mechanism supports its use as a continuous, once-daily maintenance treatment.

Q: Does Amlodipin HEXAL interact with certain antibiotics?

A: Yes, some antibiotics, such as clarithromycin, are potent inhibitors of the CYP3A4 enzyme system responsible for metabolizing amlodipine. When taken together, these antibiotics can significantly increase the level of amlodipine in the blood, potentially increasing the risk of side effects like low blood pressure or fluid retention. This may indicate the need for dosage adjustment, which is determined by a healthcare professional.

Q: What is the general safety profile of Amlodipin HEXAL in people with kidney conditions?

A: Official prescribing information states that the way amlodipine is processed by the body is not significantly altered by renal impairment (kidney conditions). Therefore, a change in the starting dose is not usually necessary for individuals who have pre-existing kidney conditions.

Q: Can Amlodipin HEXAL make my skin more sensitive to the sun?

A: Regulatory documents do not list increased sensitivity to the sun (photosensitivity) as a common side effect of Amlodipin HEXAL. While rare reports of this reaction may be found in medical literature for calcium channel blockers, it is not a typically frequent adverse event.

Q: Does Amlodipin HEXAL interact with cold and flu remedies?

A: Official interaction data suggests caution when using amlodipine with certain over-the-counter cold and flu remedies. Some of these remedies contain ingredients that can potentially counteract the blood pressure-lowering effect of amlodipine or increase cardiovascular risk. Reviewing co-administration with a healthcare provider is generally recommended.

Q: Is Amlodipin HEXAL used to treat any conditions other than high blood pressure and angina?

A: In addition to treating high blood pressure and chronic stable angina, amlodipine is officially indicated for patients who have angiographically documented coronary artery disease (CAD) but do not have severe heart failure. All labeled uses are related to circulatory management.

Q: Can I drive or operate machinery while taking Amlodipin HEXAL?

A: Official health authorities advise using caution when driving or operating machinery while taking Amlodipin HEXAL. This is because documented side effects, such as dizziness, headache, and fatigue, may affect one’s ability to perform these tasks safely. This risk may be higher when first starting the medication.

Q: Are there any long-term monitoring requirements for people taking Amlodipin HEXAL?

A: General monitoring by a doctor is expected for any long-term treatment of chronic conditions. Regulatory documents specifically recommend frequent monitoring of blood pressure when Amlodipine is co-administered with certain interacting drugs, such as those that increase or decrease its concentration in the blood.

How should Amlodipin HEXAL be stored and disposed of?

How to Store and Dispose of Amlodipin HEXAL?

Regulatory documents establish the official requirements for storing and disposing of amlodipine tablets, ensuring product stability and environmental responsibility.


Storage Requirements

Amlodipin HEXAL must be stored at Controlled Room Temperature, typically 20 C to 25 C. The tablets require protection from light and moisture and must be kept in the original packaging. It is a mandated instruction to keep the medicine out of the sight and reach of children.


Disposal Instructions

Any unused or expired Amlodipin HEXAL must be handled according to the official local requirements for pharmaceutical waste. The medicine should not be disposed of via wastewater or household rubbish to prevent environmental contamination. Consult your pharmacist for collection programs.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Amlodipin HEXAL found in:

A-Z Index: